|
TUBGCP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.589600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.022600E-04 |
| Normal-vs-Stage2 |
1.677770E-01 |
| Normal-vs-Stage3 |
4.760900E-03 |
| Normal-vs-Stage4 |
1.683860E-02 |
| Stage1-vs-Stage2 |
2.978200E-01 |
| Stage1-vs-Stage3 |
9.353200E-01 |
| Stage1-vs-Stage4 |
9.733400E-01 |
| Stage2-vs-Stage3 |
4.633200E-01 |
| Stage2-vs-Stage4 |
5.434400E-01 |
| Stage3-vs-Stage4 |
9.380000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.020800E-04 |
| Normal-vs-AfricanAmerican |
6.325000E-03 |
| Normal-vs-Asian |
1.083960E-03 |
| Caucasian-vs-AfricanAmerican |
6.248400E-01 |
| Caucasian-vs-Asian |
1.923790E-01 |
| AfricanAmerican-vs-Asian |
2.044800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.041900E-04 |
| Normal-vs-Female |
2.676000E-02 |
| Male-vs-Female |
1.875640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.437220E-03 |
| Normal-vs-Extreme_Weight |
8.2342000000013E-05 |
| Normal-vs-Obese |
2.248400E-02 |
| Normal-vs-Extreme_Obese |
4.837200E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.157400E-01 |
| Normal_Weight-vs-Obese |
1.817820E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.724200E-01 |
| Extreme_Weight-vs-Obese |
4.348300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.975400E-01 |
| Obese-vs-Extreme_Obese |
2.290000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.047520E-02 |
| Normal-vs-Age(41-60Yrs) |
1.480090E-02 |
| Normal-vs-Age(61-80Yrs) |
1.163040E-04 |
| Normal-vs-Age(81-100Yrs) |
2.523000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.526600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.889200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.522200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.623500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.490650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.506400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.444200E-03 |
| Normal-VS-Type2 PRCC |
2.194900E-04 |
| Normal-VS-KIRP CIMP |
5.464600E-03 |
| Normal-VS-Unclassified PRCC |
2.302600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.805760E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.349600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.851200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.183600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.303700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.114800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.57810000001035E-06 |
| Normal-vs-N1 |
1.399230E-01 |
| Normal-vs-N2 |
2.437400E-03 |
| N0-vs-N1 |
9.360100E-02 |
| N0-vs-N2 |
2.987400E-01 |
| N1-vs-N2 |
1.618410E-01 |
|
|
